Marcio C Mancini Selected Research

Obesity

8/2023	"Anti-obesity medications" or "medications to treat obesity" instead of "weight loss drugs" - why language matters - an official statement of the Brazilian Association for the Study of Obesity and Metabolic Syndrome (ABESO) and the Brazilian Society of Endocrinology and Metabolism (SBEM).
1/2023	Treatment with Antiobesity Drugs in Weight Regain After Bariatric Surgery: a Retrospective Cohort Study.
6/2022	Evaluation of fecal microbiota and its correlation with inflammatory, hormonal, and nutritional profiles in women.
1/2018	Genetic Variations in Sweet Taste Receptor Gene Are Related to Chocolate Powder and Dietary Fiber Intake in Obese Children and Adolescents.
1/2018	Effects of clomiphene citrate on male obesity-associated hypogonadism: a randomized, double-blind, placebo-controlled study.
8/2017	Assessment of Weight Loss With the Intragastric Balloon in Patients With Different Degrees of Obesity.
1/2017	Safety assessment of combination therapies in the treatment of obesity: focus on naltrexone/bupropion extended release and phentermine-topiramate extended release.
1/2017	The burden of obesity in the current world and the new treatments available: focus on liraglutide 3.0 mg.
3/2016	Cognitive Effects of Intentional Weight Loss in Elderly Obese Individuals With Mild Cognitive Impairment.
10/2015	The effects of exercise training in a weight loss lifestyle intervention on asthma control, quality of life and psychosocial symptoms in adult obese asthmatics: protocol of a randomized controlled trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marcio C Mancini Research Topics

Disease

19	Obesity 08/2023 - 01/2005
15	Weight Loss (Weight Reduction) 08/2023 - 01/2005
4	Type 2 Diabetes Mellitus (MODY) 04/2021 - 01/2005
4	Insulin Resistance 01/2019 - 01/2005
4	Hypertension (High Blood Pressure) 01/2017 - 01/2005
3	Asthma (Bronchial Asthma) 01/2018 - 10/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 04/2021
2	COVID-19 04/2021 - 01/2020
2	Body Weight (Weight, Body) 01/2019 - 01/2008
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2023
1	Binge-Eating Disorder (Binge Eating Disorder) 01/2023
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2018
1	Infertility (Sterility) 01/2018
1	Chronic Disease (Chronic Diseases) 01/2017
1	Inflammation (Inflammations) 01/2017
1	Cognitive Dysfunction 03/2016
1	Dementia (Dementias) 03/2016
1	Hypertriglyceridemia 08/2015
1	Hypoglycemia (Reactive Hypoglycemia) 12/2014
1	Dumping Syndrome (Syndrome, Dumping) 12/2014
1	Atrial Flutter (Flutter, Atrial) 06/2010
1	Overweight 01/2010
1	Glucose Intolerance 01/2008
1	Hypothyroidism 10/2005
1	Dyslipidemias (Dyslipidemia) 01/2005

Drug/Important Bio-Agent (IBA)

6	Orlistat (Xenical)FDA Link 01/2023 - 01/2005
5	sibutramine (Meridia)FDA Link 01/2023 - 01/2005
4	Anti-Obesity Agents (Antiobesity Drugs)IBA 08/2023 - 01/2005
3	Topiramate (Topamax)FDA LinkGeneric 01/2023 - 01/2005
3	Triglycerides (Triacylglycerol)IBA 01/2019 - 04/2012
3	salicylhydroxamic acid (SHAM)IBA 01/2018 - 10/2015
3	Glucose (Dextrose)FDA LinkGeneric 08/2015 - 01/2008
2	LeptinIBA 06/2022 - 03/2016
2	GhrelinIBA 06/2022 - 03/2006
2	Insulin (Novolin)FDA Link 01/2019 - 01/2008
2	FatsIBA 01/2018 - 03/2016
2	FenfluramineIBA 01/2017 - 01/2005
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 03/2016
2	Bupropion (Wellbutrin)FDA LinkGeneric 01/2017 - 01/2005
2	HDL CholesterolIBA 08/2015 - 04/2012
2	Diethylpropion (Amfepramone)FDA LinkGeneric 06/2010 - 01/2005
2	fenproporexIBA 06/2010 - 01/2005
1	semaglutideIBA 11/2023
1	Glucagon-Like Peptide-1 ReceptorIBA 11/2023
1	CholesterolIBA 01/2019
1	oxidized low density lipoproteinIBA 01/2019
1	VitaminsIBA 01/2018
1	Dietary Fiber FDA Link 01/2018
1	SugarsIBA 01/2018
1	Testosterone (Sustanon)FDA Link 01/2018
1	1,2-dilauroylphosphatidic acid (DLPA)IBA 01/2018
1	Clomiphene (Clomifene)FDA LinkGeneric 01/2018
1	immunoglobulin BIBA 08/2017
1	Liraglutide FDA Link 01/2017
1	Naltrexone (ReVia)FDA LinkGeneric 01/2017
1	Phentermine (Adipex-P)FDA LinkGeneric 01/2017
1	Vitamin D FDA LinkGeneric 01/2017
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2017
1	CarbohydratesIBA 03/2016
1	Apolipoproteins E (ApoE)IBA 03/2016
1	C-Reactive ProteinIBA 03/2016
1	ApolipoproteinsIBA 03/2016
1	MicronutrientsIBA 12/2014
1	SuspensionsIBA 12/2014
1	Fluorocarbon PolymersIBA 02/2012
1	LipidsIBA 01/2008
1	Nonesterified Fatty Acids (NEFA)IBA 01/2008
1	CytokinesIBA 01/2008
1	IncretinsIBA 01/2008
1	Lipase (Acid Lipase)FDA Link 01/2008
1	RimonabantIBA 04/2006
1	Cannabinoid Receptor AgonistsIBA 04/2006
1	Growth Hormone (Somatotropin)IBA 03/2006
1	Thyroxine (Levothyroxine)FDA LinkGeneric 10/2005
1	Thyroid HormonesIBA 10/2005
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 10/2005
1	AntibodiesIBA 10/2005
1	Metformin (Glucophage)FDA LinkGeneric 01/2005
1	Caffeine (No Doz)FDA LinkGeneric 01/2005
1	Zonisamide (Zonegran)FDA LinkGeneric 01/2005
1	Fluoxetine (Prozac)FDA LinkGeneric 01/2005
1	Dexfenfluramine (Redux)IBA 01/2005
1	Mazindol (Mazanor)FDA Link 01/2005
1	Ephedrine FDA LinkGeneric 01/2005
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2005

Therapy/Procedure

7	Bariatric Surgery 11/2023 - 10/2005
6	Therapeutics 11/2023 - 08/2006
3	Drug Therapy (Chemotherapy) 08/2010 - 08/2006
2	Caloric Restriction 01/2017 - 03/2016
2	Gastric Bypass (Roux-en-Y Gastric Bypass) 03/2006 - 10/2005
1	Obesity Management 01/2023
1	Secondary Prevention 04/2021
1	Aftercare (After-Treatment) 01/2018
1	Contraindications 12/2014
1	Investigational Therapies (Experimental Therapy) 08/2006
1	Glycemic Control 01/2005